Dr Elizabeth Parrish Roberts, OD in Lakeland, FL - Medicare Optometry Provider

Dr Elizabeth Parrish Roberts, OD is a medicare enrolled "Optometrist" provider in Lakeland, Florida. She went to University Alabama Birmingham - School Of Optometry and graduated in 1999 and has 25 years of diverse experience with area of expertise as Optometry. She is a member of the group practice Myeyedr Optometry Of Florida, Llc and her current practice location is 4337 S Florida Ave, Lakeland, Florida. You can reach out to her office (for appointments etc.) via phone at (863) 619-2700.

Dr Elizabeth Parrish Roberts is licensed to practice in Florida (license number OPC3376) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1295722908.

Contact Information

	Dr Elizabeth Parrish Roberts, OD
	4337 S Florida Ave, Lakeland, FL 33813-1654
	(863) 619-2700
	Not Available

Healthcare Provider's Profile

Full Name	Dr Elizabeth Parrish Roberts
Gender	Female
Speciality	Optometry
Experience	25 Years
Location	4337 S Florida Ave, Lakeland, Florida
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Elizabeth Parrish Roberts attended and graduated from University Alabama Birmingham - School Of Optometry in 1999

NPI Data:

NPI Number: 1295722908
Provider Enumeration Date: 09/29/2005
Last Update Date: 03/17/2018

Medicare PECOS Information:

PECOS PAC ID: 6507827367
Enrollment ID: I20041025000658

Medical Identifiers

Medical identifiers for Dr Elizabeth Parrish Roberts such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1295722908	NPI	-	NPPES
620502000	Medicaid	FL

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	OPC3376 (Florida)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Myeyedr Optometry Of Florida, Llc	0143541037	105

News Archive

Bristol-Myers Squibb's second YERVOY Phase 3 trial on metastatic melanoma meets primary endpoint

Bristol-Myers Squibb Company today announced results from a second Phase 3 randomized, double blind study demonstrating that YERVOY (ipilimumab) prolonged the lives of patients with metastatic melanoma.

Zinc acetate lozenges may provide 3-fold increase in recovery rate from common cold

According to a meta-analysis of three randomized controlled trials published in Open Forum Infectious Diseases, zinc acetate lozenges may increase the rate of recovery from the common cold three fold. On the fifth day, 70% of the zinc lozenge patients had recovered compared with 27% of the placebo patients.

Viewpoints: Medicare's 'doctor payment problem'; a 'wasted advantage'; 'puzzling' Rand numbers

The news that a small percentage of the country's physicians collected billions of dollars from Medicare in a single year may or may not be a testament to individual greed; some of the top recipients are under investigation for allegedly bilking the system, while others work long hours delivering costly care.

BBN to explore how brain processes large amounts of partial information

Raytheon BBN Technologies has been awarded $3 million in government funding to explore new methods of modeling the brain's ability to make sense of large amounts of haphazard, partial information.

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Celgene International Sàrl, a subsidiary of Celgene Corporation today announced that the U.S. Food and Drug Administration has assigned a Priority Review designation to the supplemental New Drug Application for the use of ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for the first-line treatment of patients with advanced pancreatic cancer.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Elizabeth Parrish Roberts allows following entities to bill medicare on her behalf.

Provider Name	Myeyedr Optometry Of Florida, Llc
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1073907028 PECOS PAC ID: 0143541037 Enrollment ID: O20150603002802

News Archive

Bristol-Myers Squibb's second YERVOY Phase 3 trial on metastatic melanoma meets primary endpoint

Zinc acetate lozenges may provide 3-fold increase in recovery rate from common cold

Viewpoints: Medicare's 'doctor payment problem'; a 'wasted advantage'; 'puzzling' Rand numbers

BBN to explore how brain processes large amounts of partial information

Raytheon BBN Technologies has been awarded $3 million in government funding to explore new methods of modeling the brain's ability to make sense of large amounts of haphazard, partial information.

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Elizabeth Parrish Roberts is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Elizabeth Parrish Roberts, OD 215 1st St N, Winter Haven, FL 33881-4537 Ph: (863) 299-8908	Dr Elizabeth Parrish Roberts, OD 4337 S Florida Ave, Lakeland, FL 33813-1654 Ph: (863) 619-2700

News Archive

Bristol-Myers Squibb's second YERVOY Phase 3 trial on metastatic melanoma meets primary endpoint

Zinc acetate lozenges may provide 3-fold increase in recovery rate from common cold

Viewpoints: Medicare's 'doctor payment problem'; a 'wasted advantage'; 'puzzling' Rand numbers

BBN to explore how brain processes large amounts of partial information

Raytheon BBN Technologies has been awarded $3 million in government funding to explore new methods of modeling the brain's ability to make sense of large amounts of haphazard, partial information.

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Optometrist in Lakeland, FL

Eye Doctors Optical Outlets Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3654 Harden Blvd, Lakeland, FL 33803 Phone: 813-885-3937
Phillips Salomon & Parrish Pa Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1251 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-688-1545 Fax: 863-595-0927
Tincy Thomas, O.D Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2004 Cr 540-a, Lakeland, FL 33813 Phone: 863-937-4515
Mary W Frates, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1600 Lakeland Hills Blvd, Lakeland, FL 33805 Phone: 863-680-7000 Fax: 866-264-8519
Dr. Marion S. Lewis & Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5535 Kings Mont Dr, Lakeland, FL 33813 Phone: 863-648-4770 Fax: 888-873-4425
Ryan M Odil, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1400 S Florida Ave, Lakeland, FL 33803 Phone: 863-250-5553
Dr. Marion Stewart Lewis, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 3615 S Florida Ave, Lakeland, FL 33803 Phone: 863-940-2091 Fax: 863-940-4764

Dr Elizabeth Parrish Roberts, OD - Medicare Optometrist in Lakeland, FL

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Bristol-Myers Squibb's second YERVOY Phase 3 trial on metastatic melanoma meets primary endpoint

Zinc acetate lozenges may provide 3-fold increase in recovery rate from common cold

Viewpoints: Medicare's 'doctor payment problem'; a 'wasted advantage'; 'puzzling' Rand numbers

BBN to explore how brain processes large amounts of partial information

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Medicare Reassignments

Bristol-Myers Squibb's second YERVOY Phase 3 trial on metastatic melanoma meets primary endpoint

Zinc acetate lozenges may provide 3-fold increase in recovery rate from common cold

Viewpoints: Medicare's 'doctor payment problem'; a 'wasted advantage'; 'puzzling' Rand numbers

BBN to explore how brain processes large amounts of partial information

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Bristol-Myers Squibb's second YERVOY Phase 3 trial on metastatic melanoma meets primary endpoint

Zinc acetate lozenges may provide 3-fold increase in recovery rate from common cold

Viewpoints: Medicare's 'doctor payment problem'; a 'wasted advantage'; 'puzzling' Rand numbers

BBN to explore how brain processes large amounts of partial information

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Optometrist in Lakeland, FL